PDC and prostate carcinoma: The selective cytotoxicity of the Pr10-CPT PDC for prostate cancer cells was tested by culturing LA04, SP05, LA08, DU-145, and PC3 cells with increasing concentrations of the PDC for 48 h and measuring cellular viability.